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Abstract:  
The extraction of information form high-throughput experiments is a key aspect of modern 
biology.  Early in the development of microarray technology, researchers recognized that the 
size of the datasets and the limitations of both computational and visualization techniques 
restricted their ability to find the biological meaning hidden in the data.  In addition, most 
researchers wanted to make their datasets accessible to others. This resulted in the 
development of new and advanced data storage, analysis, and visualization tools enabling the 
cross-platform validation of the experiments and the identification of previously undetected 
patterns. In order to reap the benefits of this microarray data, researchers have needed to 
implement database management systems providing integration of different experiments and 
data types. Moreover, it was necessary to standardize the basic data structure and 
experimental techniques for the standardization of microarray platforms. In this chapter, we 
introduce the reader to the major concepts related to the use of controlled vocabularies 
(ontologies), the definition of Minimum Information About a Microarray Experiment 
(MIAME) and provide an overview of different microarray data management strategies in use 
today. We summarize the main characteristics of microarray data storage and sharing 
strategies including warehouses, datamarts, and federations. The fundamental challenges 
involved in the distribution, and retrieval of microarray data are presented, along with an 
overview of some emerging technologies.  
Keywords: Microarray, Genomics, Databases, Integration, Interoperability, Ontology. 
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1. INTRODUCTION 
A microarray is a high-density two-dimensional matrix where thousands 
of nucleic acid, proteins or tissues are immobilized on the surface of a glass 
slide, nylon filter, or silicon wafer.  The primary purpose of a microarray is 
to perform biological screening experiments at the whole genome scale.  
Each ‘spot’ represents a single biochemical assay ‘probe’ against a particular 
object of biological interest, perhaps measuring the expression level of a 
gene, or the binding efficiency of a genomic regulatory element.  Using this 
technology, researchers effectively perform tens of thousands of 
measurements in parallel. 
 
There are many ways to perform the “spotting” process by which samples 
are placed on a microarray.  In contact printing, mechanical pins can be used 
to robotically transfer micrograms of probe from storage trays onto slides or 
membranes. In non-contact printing, ink-jet style printing techniques spray 
various amounts and configurations of probe.  Finally, in situ synthesis using 
photolithographic methods can build cDNA or RNA strands, residue by 
residue. Because of the distinction between sample spotting and 
photolithography, the latter are sometimes referred to as “DNA Chips.”  For 
the purposes of this document, we refer to both techniques as “microarrays.”  
Both contact and non-contact printing give spots of 100 µm in diameter, 
while photolithography spots are about 20 µm. These processes produce 
microarrays with spot densities from 10,000 to 250,000 spots per cm2. 
 
Because the spots printed on an array surface are typically less than 200 
µm in diameter, microarrays need to be read by specialized scanners. Most 
commercially available microarray scanners are inverted florescent 
microscopes that acquire data at two wavelengths (generally used to record a 
test and a control signal) using 532 nm (17 mW) and 635 nm (10 mW) 
lasers. The output of this process will be an image file (~5 Mb) and a text 
file (~1.5 mb).   The text file provides primary data on the intensity ratios of 
the two wavelengths, averaged over the area of each spot.  In order to assess 
the contribution of experimental noise and error inherent in this new 
technology, it has become standard process, in contact and non-contact array 
manufacture, to place an abundance of replicates of each probe on a single 
microarray.  In addition, most experiments involve multiple copies/instances 
of each microarray. A single microarray experiment might involve 
measuring the expression of a particular set of genes at one hour intervals 
during the 24 hour following exposure to some environmental stress.  This 
would produce, with even modest experimental redundancy, nearly half a 
gigabyte of primary data. 
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In less than a decade, microarrays have become a widespread technology 
used for the exploration of molecular activity of biological systems. Since 
their development, more than 12,000 publications have relied on them for 
primary experimental results.  This demonstrates their impact on biological 
sciences. The wide use of microarrays is the result of two factors:  the 
decreasing cost of reagents and instruments, and the fact that they are so 
effective as an experimental technique. Today, the end cost to a researcher, 
to measure the expression of a gene is approximately $0.05 [1].  Of course, 
this assumes that the researcher is willing to measure gene expression in 
batches of tens of thousands.  The high number of probes permits the 
exploration of complete genomes, including non-coding regions [2, 3]. The 
diversification of microarray technology to include tissues [4-6], proteins, 
and peptides permits interrogation of the molecular activity of the cell at 
many levels of resolution [1, 7].  
 
An increasing number of laboratories are using microarray-based 
analysis for disease fingerprinting, toxicological assessment, single 
nucleotide polymorphism (SNP) analysis, reconstruction of signal 
transduction pathways, and phylogenomic and epigenetic analysis [8-12]. 
Microarrays are also ideal for fast, sensitive, specific, and parallelized 
detection and diagnosis of microorganisms [13].  This has applications in 
primary research, clinical medicine, and biodefense. Several researchers 
have used microarrays for the genotyping of influenza viruses [14, 15]; drug 
resistant HIV-1 [16]; polioviruses [16];  human papiloma [17]; RNA 
respiratory viruses [18, 19]; hepatitis B and C [20]; and African swine fever 
[17, 21]. 
 
In the early stages of microarray technology development, researchers 
recognized that, due to the size of the datasets involved, computational 
analysis would be required to properly exploit the information. Early 
microarrays were very expensive, and for this reason several researchers 
restricted themselves to analyzing datasets published by others. At this stage, 
the sharing of microarray data was mainly accomplished by exchanging flat 
files. This enabled progress, despite the lack of standards to exchange 
genomic information.  The key to this success, however, was the personal 
communication between the researcher who had done the physical 
experiment and the one doing the analysis.   The use of flat files coupled 
with the lack of direct communication has several limitations.  The primary 
problem is in the exchange of experimental parameters, the “ metadata”  
without which the raw data is meaningless.  Most microarray experiments 
are composed of many different gene expression data files.   To understand 
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the biological significance of its content it is necessary to integrate several 
types of genomic information (e.g. the assignment of the molecular function 
of genes, the history of the samples used on the microarray, the batch and lot 
numbers of the slide, the settings of the scanner, and so on).  There is also 
difficulty involved in retrieving a subset of genes and expression values 
from flat files without extensive script programming information. 
Nonetheless, a main advantage of the use of flat file format is that 
microarray data could be provided as is.  
 
Spreadsheets are another file format used to store and share microarray 
data. This format not only allows sorting and filtering, but also makes it 
possible to perform basic calculations and to produce graphical 
representations using add-ins and collections of macros developed 
specifically to analyze microarray data [22-24]. Unfortunately, spreadsheets 
are difficult to update or manage remotely. Moreover, the proprietary format 
of this platform has limited impact in the extensive exchange of microarray 
data. For this reason, researchers typically link spreadsheets with web pages 
in the context of their publication. While requiring little effort to implement, 
the content and quality of the information contained within the spreadsheets 
is dependent on the algorithms used for normalizing, filtering and analyzing.  
Of course, the above mentioned limitations of metadata transfer apply just as 
much to spreadsheets. 
 
The wide availability of microarray data has fueled the development of 
exploratory research and the generation of new hypothesis about specific 
biological processes based on the analysis of large amounts of data. A 
typical example is the dataset published by Golub et al. [25]. It has been 
analyzed by different researchers using a variety of statistical and 
computational methods [26-34]. Because different algorithms applied to the 
same data can provide new insights about a particular biological process, the 
integration of different experiments through automated database 
management systems can have a significant impact on 
understanding/interpretation.  This phenomenon has already been seen with 
databases storing genomic and protein sequence data.  With the emergence 
of the study of biological systems in a holistic manner (also known as 
biocomplexity or systems biology), the analysis of microarray data is placed 
in conjunction with that of the other omic datasets [18, 35-37].  This has 
enabled the development of multi-resolution molecular maps of specific 
biological processes. 
 
Currently, around 3% of more than 400 biological databases store 
microarray data [35, 38, 39]. However, many researchers performing 
microarray experiments are unfamiliar with database concepts and perceive 
6. MICROARRAY DATA MANAGEMENT 111
 
data management systems as black boxes for data input and retrieval. With 
this in mind, the objective of this chapter is to introduce the reader to the 
basic concepts related to the storage, use, and exchange of microarray data 
including: 
 
x A description of the use of ontologies to provide a structured vocabulary 
for cataloging molecular components of the cell as well as details about 
microarray experiments.  
 
x An overview of different data models to exchange genomic information, 
including the minimum information about a microarray experiment 
(MIAME) standard. 
 
x A description of different microarray database management systems.  and 
the main characteristics of microarray data integration projects, including 
data warehouses, datamarts, and federated databases. 
 
x An overview of new developments in data storage, exchange and high 
performance computing for the implementation of enterprise data and 
microarray knowledge management systems. 
 
x A highlight of the main challenges and opportunities related to the 
development of new exchange systems and the access to data streams. 
2. MICROARRAY DATA STANDARIZATION  
The issue of data standards, integration, and interoperability has long 
been of interest to biologists.   DNA and protein sequence formats like those 
used by Genbank, Swissprot, and PDB reflect such need.  The structure of 
this information allows researchers to write specific parsers to retrieve 
subsets of information which are in an XML or flat file format.  When 
analyzing nucleic or amino acid sequences, researchers are interested in 
obtain information other than the sequence data.  For example, they might 
want to know about genomic context: the length of the open reading frame, 
the frequency and location of known introns, the chromosomal location, and 
any putative molecular function. In most cases, this information is stored in 
separate databases.  
 
Because most microarray experiments measure the transcriptional 
activity of genes, the information about a particular gene is very relevant.  
Additionally, since the variability and reliability of the experiment is 
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affected by multiple factors, microarray analyses require detailed 
information about the experiment itself before the raw data can be 
interpreted at all. 
 
A typical experiment using microarrays involves a team of researchers. 
Each member has skills in a particular process: from tissue preparation, 
microarray production (or selection from a corporate provider), RNA 
extraction and cDNA dye labeling, operation of the microarray scanner, 
normalization and data analysis. Some of these steps may even be 
outsourced to external sources.  During each step, different sources of noise 
and variability are introduced. As a result, missing data, outliers and 
variability across replications and laboratories is very common. A researcher 
integrating different microarray datasets must know the strengths and 
weaknesses of each, as well as their relative level of appropriateness for the 
current investigation. 
 
To integrate different databases, we must establish points of reference in 
the metadata and compare the data from various experiments in light of 
those reference points. Comparing free text definitions is very difficult. 
Different research groups may come up with different definitions for a 
particular experiment or biological process. They also may use very similar 
words to describe fundamentally different processes. For instance, a 
researcher might use the term DAG to mean directed acyclic graph, but for 
most cell biologists it will be the shorthand for diacylglycerol, a key 
intracellular signaling component in the calcium transduction cascade. 
Therefore, when integrating genomic information, the reader should be very 
aware that biology is a massive and dynamic field of experimental study.  
Word meanings are not stable between experimental domains, and as new 
discoveries are made, new data definitions of genes, genomes and biological 
systems emerge.  
 
To facilitate the retrieval of genomic information and the exchange of 
microarray data, researchers recently have begun to agree on a common set 
of terminologies and a minimum set of parameters that should be used to 
describe experiments involving this technology. The formation of 
government initiatives for the standardization of protocols and reagents, as 
well as the use of microarrays in clinical studies and for the diagnosis of 
pathogens, has prompted this need. In order to provide the reader with the 
overall understanding of the significance of these implementations, we will 
review concepts related to the gene and microarray ontologies and the 
Minimum Information About a Microarray Experiment (MIAME) standard. 
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2.1 Gene Ontologies 
The abstraction of real-world concepts is very important in the creation of 
information exchange systems and the management of knowledge.  Most 
applied mathematics is based on this fundamental truth.   In the early 1990’ s 
the artificial intelligence community developed a framework for the use of 
controlled vocabularies to capture and formalize the knowledge in a 
particular domain. Ontologies specify the terms or concepts and 
relationships among terms and their intended correspondence to objects and 
entities that exist in the world.  Domain ontologies are specialized 
collections of names for concepts and relations organized in a particular 
order. These descriptions and rules are accepted by a community in an 
interdependent fashion. They allow computer generated queries to filter and 
retrieve information based on user defined constraints [40-42]. 
 
Figure 1. Abstraction of different ontology levels. Adapted from Soldatova and King [46]. 
While upper categories are useful for generating the structural backbone of the intermediate 
and domain ontologies, the domain hierarchy requires more complex logical expressions.  
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The implementation of ontologies can be accomplished using specialized 
development environments, including the Knowledge Interchange Format 
(KIF), Ontolingua, WebOnto, Kosmos, Cyc and Protégée. However, 
ontologies vary in their coverage, quality and resolution. From an 
implementation point of view, three main types of knowledge representation 
can be can be distinguished: 
 
x Upper ontologies: also called high-level, core or reference ontologies, 
describe common general concepts across different communities (e.g. 
SUMO, and WorldNet).  
 
x Intermediate ontologies: are shared ontologies among domains that 
allow for scalability and join domain and upper ontologies.  
 
x Domain ontologies: are restricted in their scope and coverage to interest 
of a particular domain (e.g.: plant ontology, human anatomy ontology, 
gene ontology, microarray ontology).  Domain ontologies join and leave 
intermediate and upper ontologies and are in constant development.  
 
The sequencing of genes and genomes led to the proliferation of many 
biological databases. The information contained in these repositories was 
designed to be populated and accessed by humans, rather than by computers, 
and was littered with inconsistencies. The functional role of genes tended to 
be annotated as free text phrases.  Many of these where classified into 
arbitrary categories. At the very least, competing spellings of common terms 
made simple text searching unwieldy.  As a result, it was difficult to search 
the databases for the function of a particular gene or biological process. 
Integrating these repositories was a Herculean task, usually only undertaken 
within a fairly small community surrounding a particular area of research.  
 
To address these issues, Schulze-Kremer [40] proposed the use of 
ontologies to provide a standardized description of objects and process 
related to molecular biology. An ontology for the molecular function, 
biological process and cellular components of genes was proposed by The 
Gene Ontology Consortium (GOC) [43]. Their effort lead to the 
implementation of independent terminologies for species, as well as 
classifications related to genes.   
 
The GO now has approximately 17,000 terms and several million 
annotated instances describing how gene products behave in a cellular 
context. A particular term is linked directly to some datum in a public 
database. The GO is used by at least 30 major bioinformatic databases 
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serving researchers interested in more than 140 organisms. Each term in the 
gene ontology is accessible by a unique identifier (GO ID) and every 
annotation must be attributed to a source which may be a literature reference 
or a computer generated annotation.  
 
In a relatively short time, the GO has been adopted by the biological 
community.  Its impact is due to the strictness and expressiveness that allows 
software architectures to compute and associate biological information from 
disparate databases.  The GO has also gained considerable credibility for 
simply starting with a large, overlapping set of definitions, rather than 
haggling over an exact data modeling standard.  For these reasons, the GO 
has become the de facto standard for biological database ontologies[44]. 
 
The graphical representation of the gene ontology is made as a semantic 
net or conceptual graph (both of which are instances of a directed acyclic 
graph- DAG).  A DAG consists of a set of nodes, and a set of edges. An 
edge is a pair of nodes and the order of the nodes in the edge makes a 
difference; i.e. the edge (a,b) is different from the edge (b,a).  This type of 
representation is ideal for critical path analysis and for understanding the 
relationships between different hierarchical categories of the gene ontology 
(Figure 2).  
 
116 Chapter 6 
 
Figure 2.  Figure 2. DAG representation of the ontological arrangement of the biological 
function of twenty genes of malaria (Plasmodim falciparum). Please note that several nodes 
are shared by different parts of the tree. 
2.2 Microarray Ontologies (MO) 
An effective microarray database should allow researchers involved in 
data analysis to pose a query in terms used by an experimentalist, and 
retrieve a unified dataset from multiple sources.  This, however, requires 
knowledge of the experimental parameters affecting the reliability and the 
quality of a particular microarray experiment. To properly join the concepts 
and definitions describing these experiments and to facilitate automated 
querying and exchange of this microarray data, a group of public and private 
researchers formed the MGED Ontology Working Group [45]. This effort is 
standardizing the terminology required to publish a microarray experiment.  
The MGED Ontology Working Group is composed of computer scientists, 
developmental biologists, toxicologists, and the whole microarray 
community. This group is collaborating on the makeup of a microarray 
ontology (MO) using each member’ s knowledge for their area of expertise. 
MO uses the Protégée development environment and is divided into two 
parts [46]. The core layer is a static ontology describing only essential 
concepts about microarray experiments.  This layer is intended to be 
relatively static. The extended layer describes concepts related to microarray 
experiments and changes as biological knowledge and microarray platforms 
evolve (Figure 3). 
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Figure 3. The figure shows the detailed concept hierarchy for <ExperimentPackage> and 
<ExperimentDesignType>.  Courtesy of L. Soldatova and R. King [46].  
MO and GO are the first attempts to formalize in a consistent way the 
description of experiments and the molecular components of the cell. 
Although the design and implementation of these integration infrastructures 
is still under development; Soldatova and King [46] have pointed several 
awkward linguistic issues in the naming policy and the design of the GO and 
in particular, the MO.  The fact that GO and MO do not contain enough 
terms to describe actual microarray experiments or biological processes 
limits its mapping, alignment and merging to intermediate and upper 
ontologies.  Also in several instances MO uses the same name at different 
levels of abstraction and allows multiple inheritances of properties.  Despite 
the obvious limitations, MO and GO avoids subjective interpretations of the 
meaning of microarray experiments and gene descriptions. However, as new 
experiments become available, its redesign or reconstruction is becoming 
obvious. 
  
2.3 Minimum Information About a Microarray 
Experiment (MIAME) 
To achieve the integration of microarray datasets, researchers need to 
agree not only on the GO (what we are using or observing) and MO (what 
data we are collecting), but also on the manner in which the experiment is 
being conducted.  There is a considerable variability in both reagents and 
reference controls, and therefore, it is difficult to compare microarray data 
generated by different laboratories [7, 47].  The MIAME strictly defines 
each of the parameters that should be reported in order to provide sufficient 
information to allow an outsider to interpret the experiment [48].   Most 
importantly, the MIAME is facilitating microarray applications in clinical 
and diagnostic settings. The MIAME- annotation has six major sections:  
 
x Experimental design  
x Array design  
x Samples  
x Hybridization  
x Measurements and  
x Normalization 
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An updated summary of the MIAME guidelines is available in the 
MGED society website. In addition, the MIAME is also serving as a 
blueprint for standardization specific type of experiments [49, 50].  MIAME-
Tox includes descriptors for the inclusion cell types, anatomy terms, 
histopathology, toxicology, and chemical compound nomenclature in the 
context of toxicogenomics and pharmacogenomics research [51-53].  
3. DATABASE MANAGEMENT SYSTEMS  
The storage, exploration, and exchange of microarray data require 
computer systems capable of handling many simultaneous users, performing 
millions of data transactions, and transfering many terabytes of data in a 
secure and reliable way. Fortunately, there is a robust field of software 
development known as database management systems (DBMS) dedicated to 
exactly this task. DBMS tools are frequently referred to as “ databases,”  
which leads to confusion between the software infrastructures used to 
manage the data (the DBMS) and the collection of data being managed.  In 
this section, we are discussing DBMS software.  Examples include products 
such as Oracle, Sybase, DB2, and MySQL.  The use of a DBMS can provide 
many benefits:  secure access to both journal published and unpublished 
data, the elimination of redundant, inconsistent and outdated information, 
reliable data storage and retrieval, data provenance and historical recovery. 
 
There is no reason to limit a DBMS to storing only primary data.  It is 
also possible to use DBMS to store “ data about data,”  or metadata.  
However, metadata requirements must be identified a priori, and should 
include scientific, computing and administrative considerations.  Using the 
metadata, researchers can compose queries that incorporate the quality, 
condition, or even physical location. From an implementation point of view, 
we can divide metadata into:  
 
x Technical metadata:  This information is primarily used to support the 
work of the staff that is deploying and implementing a particular DBMS.  
Technical metadata describes the physical organization of the database, 
the access policies, user accounts, and the integrity constraints that allow 
the system to operate effectively.  
 
x Microarray metadata: In the context of this document, is the data 
annotated using the MIAME and GO standards, including the use of the 
MO.   
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Using a DBMS, one can vastly accelerate the process of data exchange 
and analysis and therefore, researchers can improve their understanding of 
specific biological processes.  However, in contrast to data shared via flat 
files, data stored in a DBMS must conform to specific rules within a 
mathematical framework known as the data model. 
 
A data model is a conceptual representation of the mathematical rules 
that define the relationships between different components of a database.  In 
other words, the data model defines what data is required, and how it should 
be organized.   Over the years, database researchers have proposed six main 
data models: file processing, hierarchical, network, relational, object-
oriented, and the object-relational. In this document, we focus in on the last 
three data models which are commonly used to exchange microarray 
information.  
3.1 Relational Data Model (R-DM) 
The relational data model was developed by Codd (1970).  The main idea 
behind this approach is the representation of data in two dimensional tables. 
This data structure in many ways drove the enterprise adoption of computers 
in financial, business and research applications.  The basic elements of the 
relational data model are the table (or relation) that is composed of rows 
(tuples) and columns (attributes). Each table has a unique attribute known as 
the primary key that identifies a tuple. Relationships between two tables are 
made by matching their primary key values. While, the primary key of each 
table can never be a null value, a foreign key permits the association of 
multiple tables defined by a schema. The term schema is often used to refer 
to a graphical depiction of the database structure (Figures 4, 6 and 7) and 
defines the fields in each table, and the relationships between fields. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic representation of different elements of the relation or table. 
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The mathematical basis of the relational model results in a series of 
algebraic operations to manipulate the data.  These include SELECT, 
PROJECT, JOIN, PRODUCT, UNION, INTERSECT, DIFFERENCE and 
DIVIDE.  These commands allow the user to combine, filter and retrieve the 
attributes of different tables. For example, to retrieve the expression values 
of a cluster of 300 genes from only 12 of the 48 time point series 
experiment, the user needs to select the 300 primary keys that identify those 
genes, and join those keys with attributes from each of the 12 tables. The 
basic query specification consists of “ SELECT attributes (300 genes IDs) 
FROM table names (time points 1 to 12)” .  The most common language for 
expressing queries of this sort is the Structured Query Language (SQL). 
However, it is necessary to clarify that there are several variants of the 
relational model. There are several software implementations capable of 
performing queries using the relational model. These relational database 
management systems (RDBMS) include: Oracle, Sybase, DB2, Informix, 
PostgreSQL, MySQL, and MS-Access.  
3.1.1 Notation of the Relational Model 
Whether the implementation of a relational database is intended to serve 
the needs of a large number of researchers or small workgroup, the planning 
of its design is an important step ensuring future performance of the 
database.  Notation is a logical and graphical design technique often used to 
allow designers, implementers and users to understand in advance the 
mathematical relationships encoded by the database. The notation is also a 
valuable graphical representation that facilitates the redesign and update of 
the database.   
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Figure 5. Basic components in the notation of the relational model. The connectivity of a 
relationship describes the mapping of associated entity instances in the relationship. The 
cardinality of a relationship is the actual number of related occurrences for each of the two 
entities. The basic types of connectivity for relations are: one-to-one, one-to-many, and many-
to-many.   
 
Figure 6. Diagram of a different tables and the overall relational microarray database 
structure of the ArrayDB [50]. Courtesy of A Baxevanis. The  schema  is  partitioned  into  
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non-disjointed  sub-schemas according   to  the  needs  of  the  different  divisions  within  the 
enterprise and the different sub-applications. Relationships between abstract categories are 
shown by arrows between the categories’ rectangles.  The name and type of the relation are 
indicated on the arrow. 
 
 
Figure 7. Schema notation of the BioArray Software Environment (BASE) [54]. Courtesy of 
L Saal. All BASE source code is publicly available to academic and commercial sites under 
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the GNU General Public License. Notice that the design of BASE involves first creating a 
schema to describe the structure of the database and the rules for the interactions for each 
table.  
3.1.2 Limitations of the Relational Model 
The relational model is simple to understand and use, even for those who 
are not experienced programmers.  However, the use of the R-DM is poorly 
suited to the integration of microarray experiments with other types of 
genomic information.  The relational model does not handle certain forms of 
data well including images, sequence data and digital documents. These 
limitations can restrict the scalability and interoperability of a relational 
database or the type of services that the implementation can provide.  
 
Since most microarray experiments are very complex, the design of the 
relational database needs to consider the possibility of creating or updating 
new tables.  As the number of tables increase, a more complex phrasing is 
necessary. As this information is scattered across relations, the query process 
becomes dependent on the scalability of the system. Because adding and 
updating tables may be cumbersome, a single very large table with many 
attributes may be generated.  However, many tuples might be empty.  This is 
functionally equivalent to a flat file, that is non scalable.  
 
Another main disadvantage of the R-DM is the separation of the schema 
from the application software.  This makes updating the schema difficult.  
This is further complicated due to the constant evolution of biological 
databases and their respective schemas.  To change the schema, the user 
needs to understand, at some level, the entire set of tables and the intricate 
relations of whole design. Since schemas are more valuable when they 
represent a clear view of the components of the database, schemas should 
not be affected by implementation considerations, such as limits on the 
number of classes, tables, or attributes. Therefore, while constructing global 
schemas it is necessary to detect semantic conflicts among existing tables 
(such as naming inconsistencies and identical entities entered multiple 
times). 
3.2 Object Oriented Data Model (OO-DM) 
Object-oriented programming languages are the dominant form within 
development environments for large-scale software systems. This is relevant 
in biology since many genomic projects acquire a considerable amount of 
data in a short period of time. Beginning in 1980’ s, the  OO-DM was 
proposed to scale the access of biological and genomic information and to 
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address some of the limitations of the relational data model [55-65].  The 
Object Oriented (OO) data model associate actions and functional 
information along with data.  It has been referred to as “ data with attitude.”  
The OO data model encapsulates each tuple as an object into a single 
unit called class.  Since the underlying details of a class are masked behind 
access methods, objects from radically different implementations can be 
combined in a single query. This allows the OO-DM to provide access to the 
data via methods or functions which can conceal a certain amount of 
complexity.  This leads to increased portability and interoperability, since 
interfaces, rather than direct access to underlying data model features, are 
used.  Since the OO-DM provides a more intuitive structure for human 
access, and because of its inherently modular structure, OO systems tend to 
be easier to maintain and reuse than purely relational ones. Also the use of 
object identifiers (OIDs) used to reference the accession methods in objects, 
makes the code more scalable. This can lead to significant performance 
improvements over relational databases. 
 
Generally speaking, objects have three features: state, identity and 
extensibility.  Identity assures that we are accessing the correct object.  The 
state is characterized by a set of attributes (the data contained in the object) 
as well as any history of modification or ownership. Behavior is 
characterized by a set of methods that are applicable to the object. 
Extensibility is an especially powerful concept in software development and 
refers to the ability to add functionality to an existing system without 
fundamentally changing it. Most important is the idea that old methods of 
accessing the data should continue to work, even if new features are added. 
An object-oriented approach to programming provides extensibility in two 
ways: behavioral extension and inheritance.  Objects may be extended by 
simply adding additional methods.  This is tremendously valuable because 
developers can rely on existing behaviors in building tools that reference the 
information in the object. An OO approach further promotes extensibility 
through reuse or inheritance. It is important to note that while the 
terminology of the OO-DM is inspired in part by biology, the analogy is 
limited at best, and the biological metaphors should be taken with a grain of 
salt. 
3.2.1 Notation of the OO-DM 
Object-oriented notation and modeling is one of the key aspects in the 
development of an OO-database.  During this process the use case scenarios, 
class/object diagrams which represent the main functionality as well as the 
structural aspects of the system are presented in an intuitive manner.  The 
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procedural control flow of the whole OO-database is represented 
schematically using standardized stereotypes (Figure 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Notation of a high-level conceptual representation of the OO-RM components. The 
figure also includes the notation diagrams for the ArrayDesign object of the MAGE-OM 
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(Microarray Gene Expression - Object Model). This diagram uses the Rose Web Publisher 
and is implemented by the MGED and the European Bioinformatics Institute (EBI). Notice 
that the type of model should be indicated using the appropriate stereotype listed in top of the 
figure. 
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3.3 The eXtensible Markup Language (XML) 
XML is derived from the Standard Generalized Markup Language 
(SGML), the international standard for defining descriptions of the structure 
and content of different types of electronic documents [60]. The XML is a 
data source in that its presentation is separate from its structure and content. 
The manipulation of genomic information using XML represents an 
interesting alternative and is currently implemented in different 
bioinformatic applications including microarray data integration efforts.  
 
XML not only allows information in different representations to be 
exchanged between applications in a generic format, but also offers an 
opportunity to access information managed by heterogeneous DBMSs. The 
XML data defines the structure and content, and then a stylesheet is applied 
to it to define the presentation. Since XML data is stored in plain text format, 
XML provides a software and hardware-independent way of sharing data. 
Furthermore, XML can be used to represent the query results as datagrams, 
and XSLT (Extensible Style Language Transformation) provides a 
mechanism for transforming the datagrams into XML. 
 
The relevance of the XML framework is particularly useful for re-
ordering of microarray gene expression data.  Since XML provides a 
framework for tagging structured data that can be used for specific tag sets 
and therefore for defining standard specifications.  An XML document is 
either well–formed obeying the syntax of XML or XML valid conforming 
the logical structure defined by document type description (DTD) [60, 66]. 
The DTD is the classification system that defines the different types of 
information in any XML document. Any Web page that indicates the DTD it 
conforms to will instantly allow the user of an XML-enabled search engine 
to restrict queries to that DTD-defined space.  
 
The Extensible Markup Language/Resource Description Format 
(XML/RDF) was developed by the W3C to enhance the XML model and 
encode metadata concerning web documents.  Instead of defining a class in 
terms of the properties its instances may have, the RDF vocabulary describes 
properties in terms of the classes of resource to which they apply. 
XML/RDF as is, without a higher level formalism that encompasses the 
expressivity present in frame-based languages does not go far enough to 
allow the kind of modeling needed in the bioinformatics community. Three 
main elements are part of an XML file.  
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x XML Tag: A start tag is an element type name enclosed in angle 
brackets that opens an element.  Every start tag must have a 
corresponding end tag. An end tag finishes the content of an element, 
comprised of an angle slash and then the element type name, all enclosed 
by angle brackets.  
 
x XML Attribute: Attributes are name value pairs that are associated with 
an element type.  They follow the element type name inside the start tag.  
They can be thought of as the ’adjectives’ of XML. 
 
x XML Element: An element consists of a start/end tag pair, some 
optional attributes defined as key/value pairs and the data between the 
tags.  
3.3.1 The Microarray Gene Expression Markup Language  
Microarray Gene Expression Object Management (MAGE-OM) is a 
data-centric Universal Modeling Language (UML) that contains 132 classes 
grouped into 17 packages, containing in total 123 attributes and 223 
associations between classes reflecting the core requirements of MIAME 
[45].   MAGE-OM is a framework for describing experiments performed on 
all types of DNA-arrays. It is independent of the particular image analysis 
and data normalization algorithms, and allows representation of both raw 
and processed microarray data.  Since MAGE-OM defines the objects of 
gene expression data independent of any implementation, it allows users to 
describe the experimental process using free-text descriptions.  There are 
three abstract classes in MAGE-OM from which all the classes in the model 
derive from, Extendable, Describable, and Identifiable.  
 
The MGED society implemented the Microarray Gene Expression 
Markup Language (MAGE-ML) as an XML representation of the MAGE-
OM.  A major advantage of the MAGE-ML format is that while it supports 
information from a variety of gene expression measurements including 
related data collection methodologies; it does not impose any particular data 
analysis method [45, 67, 68].   MAGE-ML also has advantages in the sense 
that many laboratories can verify microarray experiments with other 
methodologies such as real time PCR.  MAGE-ML is organized into sub-
vocabularies in such a way that the sub-vocabularies are independent of each 
other.  These sub-vocabularies are driven by the packages and identifiable 
classes of the MAGE-OM. The MAGE software toolkit (MAGEstk) is well 
developed for Perl and Java applications. 
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3.3.2 Limitations of the OO-DM 
OO-DMs often assume a network of computers, with processing on the 
back or front end, as well as intermediate tiers, caching on each level of the 
database.  However, there are very few software systems capable to 
implement a full scale object oriented data model.  While the OO-DM offers 
scalability, there are more requirements to identify accurately different 
classes.  Therefore, the initial design is important in ensuring the future 
performance of the database.  Without a proper management of each class, 
the design will not work as per specification and the database will be 
severely impaired.  
3.4 Object-Relational Data Model (OR-DM) 
Databases with an OR-DM were developed with the aim of extending the 
relational information with three key features of the OO-DM: inheritance, 
behavior and extensibility. This functionality not only permits the 
management of native SQL data types, but also the handling of object-
oriented multimedia information (e.g. sequences, images, and video). The 
OR-DM is still relational because the data is stored in relations, but, loosely 
organized into OO hierarchical categories.  As a result, the OR-DM extends 
the R-DM by transforming the tuple as object and the table as class. While 
column holds primitive data types, the class can hold data of any type of 
data.  This allows allow attributes of tuples to have complex types, including 
non-atomic values such as nested relations while preserving the declarative 
relational access to data. This results in a very complex data structures 
known as LOBs (Large Objects).  
 
Databases designed with the OR-DM are very attractive for the 
integration of genomic and microarray information.  They are frequently 
used in web applications and specialized data warehouses; although a more 
significant impact can be seem in data federations.  A database with OR-
capabilities can execute complex analytical and multimedia data 
manipulations (i.e. images, normalized microarray data, as well sequence 
information), and transform these manipulations into new, complex objects 
make OR-DMs ideal for a research enterprise. An OR-DBMS is represented 
by the PIR database [69], ooTFD (object-oriented Transcription Factors 
Database) [59]. OR vendors provide products such Oracle, Informix, 
FirstSQL/J, OpenODB DB2, and Postgre Object-relational mapping.   
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3.4.1 Limitations of the OR-DM 
One of the challenges in the implementation of OR-DM is the design of a 
modular schema capable to allow the re-use when dealing with complex 
structures. Moreover, the translation layer between relational and object 
oriented can be slow, inefficient and very costly. This can result in programs 
that are slower and use considerable memory.  
4. MICRORRAY DATA STORAGE AND EXCHANGE  
Once in microarray experiments are in digital format, all the components 
can be shared, copied, processed, indexed and transmitted from computer to 
computer, quickly and flexibly.  The development of new technologies to 
store digital information are transforming the life sciences and enabling 
scientists to record vast quantities of data.  These advances and the 
improvement in the sensitivity of microarray technology have motivated the 
development of a considerable number of specialized databases (Table 1).  
As the relevance of microarray experiments increases, the use of this 
technology for diagnostics and clinical research present a new paradigm in 
the storage of this information. The scientific community has been 
enthusiastic about microarray technology for pharmacogenomic and 
toxicogenomic studies in the hope of advancing personalized medicine and 
drug development. The US Food and Drug Administration (FDA) is 
proactive in promoting the use of pharmacogenomic data in drug 
development.  This progress means that in the future, microarray data related 
to clinical studies and diagnostics need to comply with regulations 
mandating data preservation and access.   
 
The scope of different databases provide user with a variety of services 
and maintaining specific types of information associated with microarray 
experiments. These databases can store at least five levels of information: 1) 
the scanned images (raw data) 2) quantitative outputs from image analysis 3) 
normalized data or 4) a list of important genes after the analysis process and 
5) the metadata associated with each experiment.  
 
Microarray raw data (images) are the starting point of the analysis 
process. However, storing this information poses practical limitations 
including the size of and access to the image files. Nonetheless, considering 
the ongoing development in image analysis software, the storage of any 
processed form of the original image, without keeping the original image 
itself, can lead to the argument that the data is outdated as new image 
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analysis methods become available.  In early 2001, there was considerable 
discussion about who should maintain original microarray images and if this 
was responsibility of journals, public repositories, or research institutes.  
Despite the intense debate, no consensus has been reach about whether or 
not is cost-effective to store all this information, and, at this point, the 
publishing authors themselves are responsible for storing (and providing on 
request) original image files. Certainly, no decision has been made regarding 
if this task should be ensured by public repositories or the institutions 
hosting the author of a particular paper [35, 67]. 
 
Sharing the extracted (but not normalized i.e. CEL, GPR files) solves 
some of the practical limitations related with raw images.  This level of data 
level sharing is well suited for many microarray public and local databases. 
However, it requires the implementation of appropriate DBMS as well pre-
processing tools. Another approach to store microarray data consists in the 
sharing of normalized expression ratios or summarized values such as signal 
intensities.  In this form, much information about the experiment is lost 
because the diversity of microarray data normalization and probe level 
analysis techniques. The last form of microarray data exchange consists in 
providing a list of genes that significantly differ between experimental 
samples.  Due to the wide variability in accuracy across different analysis 
methods, this information should be limited only to publications. Finally, the 
sharing of microarray metadata is another component of the data exchange 
process; however, it has not received considerable attention. Supplying 
metadata to describe microarray experimental details is not a rewarding task, 
since it requires considerable work and there is not an immediate benefit.  
Considering that microarray experiments are done by different communities 
and have different scope, we can classify these implementations as: 
 
x Public: These types of microarray DBMSs cover different microarray 
experiments by single or different researchers, and allow users to query, 
retrieve and analyze both unpublished and published microarray 
information.  
 
x Institutional: The configuration of this type of microarray DBMS 
resembles public databases but is built around a particular organism 
and/or restricts the access to a limited number of researchers depending 
on some set of permissions defined by the institution.  
 
x Private: These microarray DBMSs are limited to researchers within a 
research group and are not available to other researchers.  
 
132 Chapter 6 
 
Table 1. Microarray Data Storage and Exchange Systems 
 
Database Name Schema Public Local MIAME Supportive Software 
Acuity No No Yes Yes SQLServer 
AMAD No No Yes No Flat File, PERL 
AMANDA No Yes Yes Yes MySQL 
Argus No No Yes No MS Web-server 
ArrayDB Yes Yes Yes Yes Sybase, PERL 
ArrayExpress Yes Yes Yes Yes MySQL, Oracle 
Axeldb Yes Yes Yes Yes Perl, FlatFiles 
BASE Yes No Yes Yes MySQL, PHP 
BioMart Yes Yes Yes Yes SQL 
CGO No No Yes No MS-Access 
CoBi No No Yes Yes Oracle 
Dragon Yes Yes Yes No MS-Access 
ExpressBD Yes Yes Yes Yes Sybase 
Expressionist No No Yes Yes Oracle8i, Web server 
GeneDirector No No Yes Yes Oracle 
Genetraffic No No Yes Yes PostgreSQL 
GeneX Yes Yes Yes Yes PostgreSQL, XML 
GEO Yes Yes No Yes Flat files 
GeWare Yes Yes Yes Yes Flat File, OLAP 
GXD_GEN Yes No No Yes Flat File 
LIMaS Yes No Yes Yes Flat File, Java 
MADAM Yes No Yes Yes Flat File, XML 
mAdb Yes No No Yes Sybase 
MARS Yes No Yes Yes MySQL, Oracle 9i  
maxdSQL Yes No Yes Yes MySQL, Oracle8i, 
M-Chips Yes Yes Yes No PostgreSQL 
MEM-5AM No No Yes Yes DB2 
MEPD No Yes No No DB2 
NASCArrays Yes Yes No Yes FlatFile, XML 
NOMAD No No Yes No MySQL 
OrionDB No No Yes Yes PostgreSQL, XML 
PartisanLIMS No No Yes Yes --- 
RAD Yes Yes Yes Yes Oracle, PHP 
READ No No Yes No FlatFile, PostgreSQL 
RossettaResolver No No Yes Yes Oracle 
SGMD No No Yes No SQLServer2000 
SMD Yes Yes No Yes Oracle, PostgreSQL 
SMD Yes Yes Yes Yes Oracle, Perl 
StressDB No No Yes Yes Oracle 
Longhorn Array Yes Yes Yes Yes PostgreSQL 
YMGV Yes No Yes No PostgreSQL, PHP 
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4.1 Microarray Repository  
Microarray data repositories are data collections that, in general, are 
implemented by one institution to serve a research community [61]. These 
storage and exchange systems allow the submission of data from both 
internal and external investigators [70, 71].  Although often used 
synonymously with data warehouse, a repository does not have the analysis 
functionality of a warehouse. The maintenance and curation of data 
repositories has made these data exchange systems of considerable value to 
specific research communities.  Since repositories need to be able to store, 
access, filter, update and manipulate large data sets quickly and accurately, 
the information requires systematic knowledge management, proper 
representation, integration and exchange.  
 
4.2 Microarray Data Warehouses and Datamarts 
Data warehouses are databases devoted to storing relevant information 
from other sources into a single accessible format [72].  These systems have 
the advantage that they can import and analyze data that cannot otherwise 
communicate with each other.  Since they incorporate a time factor, data 
warehouses can present a coherent picture of heterogeneous genomic 
sources integrated at different time points.  In fact, very often, their 
requirement is to capture the incrementally changed data (delta) from the 
source system with respect to the previous extract.  
 
Data warehouses are populated from the primary data stores in three 
main steps often through sophisticated compression and hashing techniques.  
First, data are extracted from the primary data sources.  This process uses 
monitors/wrappers that are capable of both collecting the data of interest and 
send it to the warehouse.  The monitor is also responsible for identifying 
changes in external databases and updating the warehouse automatically.  
Second, the data are transformed and cleaned.  Specific logic for data 
standardization or for resolving discrepancies between data can be 
implemented in this step.  Third, the data are loaded into the database, and 
indexes are built to achieve optimum query performance.  This configuration 
facilitates the direct access of microarray data for analysis, allowing for both 
good performance and extensive analysis and visualization capabilities.  
 
In order to standardize data analysis, data warehouses are organized as 
problem-driven small units called datamarts. These implementations are 
subsets of larger data warehouses and contain data that has further been 
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summarized or derived from a main data warehouse. Datamarts are an 
attractive option because they take less time to implement than a centralized 
data warehouse and initially cost less. However, data marts can be more 
costly in the long run because they require duplicated development and 
maintenance efforts, as well as duplicated software and hardware 
infrastructure. Additionally, scattered data marts can hinder enterprise 
performance because they often store inconsistent data, making one version 
of “ the truth”  impossible to obtain.  
 
The development of data warehouses like MaxD and DataFoundry which 
integrated SwissProt, PDB, Scop, Chat and dbEST in a unified schema 
represent a clear success of genomic data warehousing [72, 73]. First, it must 
obviate the need for the conversion and migration of data and must require 
no change to the local database system. Second, it must allow users to 
interact in such a way that both users and applications are shielded from the 
database heterogeneity. Third, allowing the interoperability of heterogeneous 
databases must allow reads and updates of these databases without 
introducing changes to them. By their nature, data federations (datamarts) do 
not modify the primary data sources and a great effort must be paid in the 
cleaning and transformation before their placement in the warehouse. Since 
data are drawn directly from the primary data stores, detection and cleaning 
of redundant data is not easily incorporated [74, 75]. 
 
 
 
 
 
 
 
Figure 9. Data warehousing approach: Several data extraction components move and 
integrate the data into the virtual warehouse. Different software applications can be used to 
analyze and represent microarray information and integrate it with other genomic data sets. 
Microarray data warehouses have three two costly drawbacks: 1) 
considerable effort required for planning the integration and 2) the great deal 
of investment required for data cleaning and transformation. This situation 
affects reliability and overall system maintenance of the system.  
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4.3 Microarray Data Federations  
Most microarray databases are specialized collections of information for 
a particular organism or biological process.  They are scattered in different 
locations and managed under difference policies. In order to integrate this 
information, a data federation schema seeks to join isolated, heterogeneous 
repositories into a single virtual main database. This process is accomplished 
without modifying the primary data sources and by avoiding the creation of 
a large warehouse. Their use is motivating the emergence of “ virtual 
organizations”  which take advantage of the standardization of microarray 
protocols and the use of reference probes. In addition, federations rely on the 
development of GO, MO, MIAME and MAGE-ML standards which permits 
the development of wrappers exploring and querying multiple data sources 
and may have different characteristics including: 
 
x Public data: data from public sources, such as ArrayExpress and NCBI-
GEO, copies of raw data may be held locally for performance reasons or 
shared throughout the federation. 
x Processed public data: public data that has additional annotation or 
indexing to support the analyses needed by different analysis algorithms.  
This information can serve as the common link for joining different 
databases within the federation.  
x Sensitive data: In many cases, an individual user will be generating data 
which remains to be analyzed or is unpublished. These require careful 
enforcement of privacy and may be restricted to one site, or even part of a 
site. 
x Personal research data: data specific to a researcher, as a result of 
experiments or analyses that that researcher is performing.  This is not 
shared even among the local team. It may later become team research 
data. 
x Team research data: data that is shared by the team members at a site or 
within a group at a site.  It may later become consortium research data, 
e.g. when the researchers are confident of its value or have written about 
its creation and implications. 
x Consortium research data: data produced by one site or a combination 
of sites that is now available for the whole consortium.  
 
While data federations could accelerate the development o data 
standards, traditional federations might be too rigid and labor-intensive to 
adapt to an open environment where new sources are integrated 
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dynamically. Therefore, before implementing or joining a data federation, 
researchers interested in this possibility need to address issues related with 
the design, interoperability and security of each transaction and the transfer 
of high volumes of information.  
 
In most cases, member databases are geographically distributed, hosted 
on a variety of platforms and administered independently according to 
differing policies, which might be independent of the federation policies.  
This means that the federated system must be designed under the assumption 
that not all resources will be available and consistent at all the times. This 
makes the quality control very difficult. Because data federations perform a 
considerable number of data transformations, query performance is one of 
the main concerns.  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Basic schematic representation of an enterprise federated system for microarray 
and other genomic information integration and management: 1) application layer, 2) 
abstraction layer and 3) metadatabase. Notice that the figure illustrates the various 
components and services based on a J2EE environment. This allows the user to make 
complex queries across multiple internal and external biological data sources.  
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4.4 Enterprise microarray databases and M-KM  
From an institutional perspective, the information generated by 
microarray experiments can be interpreted as data, values, and relations 
generated by different researchers with a shared common and main 
institutional goal [76, 77].   In this context, enterprise systems can be defined 
as computer architectures designed as intranet systems capable of 
performing pipeline operations. Using specific hardware, software, database 
management systems, agent software, analysis and visualization algorithms 
enterprise systems integrate information and find patterns and relations over 
large periods of time. The result of this process is the constant 
transformation of data into an intellectual asset (Figure 11).  The 
implementation of enterprise microarray data management systems is being 
enhanced by the development of semantic web technologies, grid computing 
and Internet2 the capacities. 
 
                        Figure 11. Enterprise Knowledge Management System for Microarray Data.  
 
The implementation of enterprise microarray data management systems 
is resulting in a new generation of infrastructures known as knowledge 
management systems (KMS).  The KM concept evolved from information 
management tools and not only to integrate data, but integrates many aspects 
of computer-supported collaborative work environments including blogs, 
wikies and discussion forums. Difference from conventional databases, 
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microarray KM tries to consolidate knowledge which is not easily codified 
in digital form, such as the intuition of key individuals with considerable 
experience interpreting data from a particular biological process, organism 
or cellular process. These individuals an/or their collective thinking might 
recognize various patterns of gene expression profiles that someone with less 
experience or a single individual may not recognize.  While promising, 
microarray KM implementation requires a series of standards to enable 
genomic information to be captured, analyzed, understood and re-applied in 
new contexts. This includes detailed technical and microarray metadata, 
learning management tools, content modularization, genomic data analysis 
workflows, supervised and unsupervised analysis algorithm and 
visualization. Therefore, the implementation of an enterprise analysis system 
requires: 
 
x Technical integration: Use nonproprietary platforms, open standards 
and methodologies in the design of the system architecture that ensure 
long-term scalability, robustness, performance, extensibility and 
interoperability with other systems and platforms.  
 
x Semantic integration: Use all levels of linked biological concepts and 
their dependencies in biological, genetic and microarray ontologies. 
Manual intervention to map data between different data sources should 
not be required. 
 
x Interoperability: Provide user with the ability to directly import and 
export gene expression data as a single flat files derived from separate 
microarray DBMSs. 
 
x Allow configurable combinations of data sources: It should be 
possible to integrate and combine different sources of biological 
information. 
  
x Evidence management: It should be possible to determine which 
computational method was used for derived data and to annotate 
mappings between databases. 
 
Microarray KM systems can be technically similar to data federations, 
however, their unique features make these systems ideal for reinforcing intra 
and multi-organizational data sharing, and to validating the description of 
the molecular organization and dynamics of specific biological processes. 
Since this information becomes takes advantage of the collective knowledge 
available from researchers within a particular research enterprise, the goals 
6. MICROARRAY DATA MANAGEMENT 139
 
and planning of the organization can be optimized (Figure 12).  The 
collaborative foundation of microarray KM is beginning to attract small 
research groups to integrate their applications into easily and seamlessly 
accessible platforms that can be used in a open environment.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 112. Graphical user interface (GUI) of OrionDB. This solution is implemented by 
Orion Integrated Biosciences Inc. as a microarray data storage and management system for 
research enterprises. When the user is logged into the system (1), the system assigns a 
personalized GUI (2) and provides access to specific projects associated with the user’ s 
privilege profile. When the user is inserting data, automatic data structures are generated (3 
and 5). In case the user needs to clarify a particular concept to annotate microarray data, MO 
based concepts can be generated by clicking on the integration symbols (4). Each microarray 
platform (5) stores metadata and data associated with each spot. This information is mapped 
to genomic and other molecular biology databases. 
5. CHALLENGES AND CONSIDERATIONS 
Microarray technology has added an important dimension and depth to 
the analysis of different and dynamic different biological processes.  The 
scientific value of this technology is enormous; however, the quality of this 
information is highly variable.  Problems in data quality have been observed 
from analyzing published data sets, and many laboratories have been 
struggling with technical troubleshooting rather than generating reliable 
datasets.  Therefore, it is important to recognize that not all datasets are 
suitable for storage and distribution.  Unless a clear description of the 
experimental design and quality experiment itself is provided (technical and 
1 2 3
4
5
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biological replicates, and the use of appropriate protocols) the query and 
retrieval of datasets should be limited to published results.  The fact that 
many of these datasets do not provide appropriate metadata makes difficult 
the incorporation of quality assessment methods. Therefore, it is necessary to 
implement semi-automated approaches that score the level of reliability of 
the data.  Developing better systems for collecting metadata, either manually 
or automatically is one of the most urgent issues needing attention.  
 
Several microarray databases and analysis software overcome national 
boundaries.  This is particularly true in the sharing of microarray data, where 
scientists on a global basis deposit and retrieve data irrespective of who 
funded the information production.  Some microarray databases have already 
surpassed a terabyte scale.  The implications of the accumulation of this 
information, has been not fully recognized. There are several critical design 
issues in databases which affect how new databases and analysis systems are 
implemented. Performance and efficiency not only needs to be measured by 
query response time, but by the time it takes a scientist extracts knowledge 
from the data.  Adopting standards which are likely to survive and/or are 
well described for the future is difficult.   Therefore, it is necessary to 
motivate the re-use of software and the development of approaches to 
decrease the risk of data loss or the expense of data resurrection.  
 
Large data repositories, computationally intensive data analysis and 
visualization tools pose difficult problems for the implementation of open 
access enterprise microarray data management and KM systems. Commonly, 
database schemas are changed without any notification, explanatory 
documentation, or appropriate notation. This makes the maintenance and 
improvement of these systems difficult.  These challenges are complicated 
by the fact that internet bandwidth and data compression technologies have 
not kept pace with the growth of scientific data sets. Many data repositories 
still provide data access primarily via FTP. While FTP-based data sharing is 
a valuable starting point, we need to encourage more robust interfaces, 
capable of retrieving specific datasets automatically. This is perhaps a main 
bottleneck in the automatic retrieval of databases since there is poor 
communication on the part of the resource maintainers. Moreover, large data 
archives are becoming increasingly ’isolated’ in the network sense. 
Therefore, in order to work with large data sets, it might be necessary to 
send computations to the data, rather than copying or moving the data across 
the internet.  
 
A limiting aspect in the development of microarray data storage and 
exchange systems is related to the complexity and dynamics of the data 
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itself. Complexity arises from the lack of unique spot identifiers and the 
existence of a large number of many-to-many relationships among clones, 
accession numbers, chromosomal location, mutation types, etc. In addition, 
microarray datasets derive the treatment of biological samples (with 
different genetic background) to multiple experimental conditions and time 
courses. The dynamics of microarray data results from the terminology used 
for the description of a biological sample and the functional role for a 
particular gene or its transcriptional variants.  These attributes can change as 
new discoveries update this information. As a result, the interpretation of a 
particular microarray dataset is highly dependent on ever-growing and 
dynamic annotation information. Although the use of microarray data 
analysis tools is beyond the scope of this chapter, the reader should be aware 
that the annotation of unknown genes using ontologies depends on analysis 
algorithms and the amount of information used in the analysis process.  It is 
now more evident that the “ guilt by association”  is not always true.   
 
The reader must be aware that deciding on appropriate terms that could 
be used in the development of microarray ontologies and mapping them to 
other middle and upper ontologies entails main decision points.  First, the 
implementation of a large and comprehensive ontology versus several 
smaller task oriented ontologies is still a subject of discussion. One 
alternative (large ontologies) presents challenges regarding agreement across 
sub-disciplines.  Second, coordination between different small ontologies 
could be very expensive. In both situations, it is necessary to consider how 
the dynamics of the ontology will affect a database.   This is important in 
biological ontologies because they do not remain static; they evolve as new 
discoveries are made.  By restricting access to or simplifying assumptions 
about a particular dataset in order to accommodate it to a particular 
ontological definition, the user risks the trivializating the queries and results.  
    
The reader should be cautious during the integration of different 
microarray datasets and the annotation of new genes based on combined 
gene expression values.  Simplistic, linear transfer of derived information 
can lead to a “ transitive catastrophe”  or “ data poisoning,”  in which one piece 
of inaccurate information can corrupt a large number of derived results.  
This legacy issue is becoming more significant since the functional inference 
of genes and transcriptional interactions changes with time and is not 
straightforward.  As more microarray data becomes available, it is becoming 
evident that biological systems are organized as transcriptional networks 
with specific modular components, rather than in a particular class or cluster 
of similar gene expression values. 
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6. CONCLUSIONS 
Since the early 1990s, when scientists first began using microarray 
devices to study gene expression, they have widened the use of this 
technology to studying how genes interact at the transcriptional, proteomic 
and metabolomic levels.  The rapid increase in the size and diversity of this 
type of information has highlighted the need for efficient computational 
techniques for data storage and exchange.  The internet has made it possible 
to access large amounts of information from multiple microarray databases 
distributed across the world. This is stimulating a growing demand for 
analysis and visualization systems of multiple and heterogeneous biological 
data sources. However, even when a global network infrastructure provides 
the foundation for the microarray data sharing and exchange, the location, 
retrieval and the combination of disparate and poorly annotated microarray 
datasets has proven to be a complex and a time consuming task.  
 
Researchers recognize the benefits of integrating microarray with other 
genomic information.  Investing in these efforts, are not only saving time, 
but also making more effective experimental designs and reducing 
experimental resource expenses.  Due to the large number of data points and 
since the analysis of the same data using different computational techniques 
can lead to a better understanding of the biological process, different 
microarray data repositories are playing a vital role in biological sciences. 
Data exploration research is now impacting traditional wet-lab experiments 
from hypothesis generation to experimental design and data analysis.  
However, how good genomic data mining is made dependents on the time 
and care that is spend when designing and implementing a data storage and 
exchange system. Specially now, that a new generation of researchers no 
longer ’do’ wet-lab experiments. Instead they ’mine’ available microarray 
databases, looking for new patterns and discoveries. 
 
The integration of data is an active research field in the computational 
sciences. However, as new technologies collect large amounts of genomic 
information in a near real time fashion, the storage and exchange of data 
streams will continue to challenge a new generation of researchers. 
Therefore, important questions in database design will need to be addressed. 
The inclusion of different data types and the communication with other very 
large databases will be one of the most important challenges for an 
integrated initiative toward the understanding of complex biological 
systems.  
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